WELLS FARGO & COMPANY/MN - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$11,633,000
-77.0%
251,110
-87.9%
0.00%
-80.0%
Q1 2019$50,599,000
+42.7%
2,075,460
-16.6%
0.02%
+25.0%
Q4 2018$35,448,000
-6.1%
2,487,552
+0.1%
0.01%
+9.1%
Q3 2018$37,766,000
+2.7%
2,484,662
+13.4%
0.01%0.0%
Q2 2018$36,780,000
-6.2%
2,191,913
-8.8%
0.01%
-8.3%
Q1 2018$39,208,000
+25.4%
2,402,389
-1.6%
0.01%
+33.3%
Q4 2017$31,256,000
-1.8%
2,441,829
-9.0%
0.01%
-10.0%
Q3 2017$31,834,000
+1352.9%
2,683,868
+925.4%
0.01%
+900.0%
Q2 2017$2,191,000
-34.7%
261,746
-30.2%
0.00%0.0%
Q1 2017$3,355,000
+1.3%
375,206
-0.4%
0.00%0.0%
Q4 2016$3,312,000
+98.7%
376,807
+52.6%
0.00%0.0%
Q3 2016$1,667,000
+102.1%
246,961
+6.5%
0.00%
Q2 2016$825,000
-23.0%
231,801
-36.2%
0.00%
Q1 2016$1,072,000
-23.5%
363,306
+9.4%
0.00%
-100.0%
Q4 2015$1,401,000
+8.0%
332,096
+16.7%
0.00%0.0%
Q3 2015$1,297,000
-2.5%
284,586
+54.4%
0.00%0.0%
Q2 2015$1,330,000
-35.3%
184,334
-33.9%
0.00%
Q1 2015$2,056,000
+183.6%
278,880
+82.1%
0.00%
Q4 2014$725,000
+2.0%
153,143
-23.0%
0.00%
Q3 2014$711,000
-40.2%
198,980
-23.7%
0.00%
Q2 2014$1,188,000
+20.5%
260,693
+24.2%
0.00%
Q1 2014$986,000
+21.6%
209,858
+29.6%
0.00%
Q4 2013$811,000
-67.5%
161,944
-59.6%
0.00%
-100.0%
Q3 2013$2,495,000
+260.5%
400,973
+163.0%
0.00%
Q2 2013$692,000152,4890.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders